Informed Consent for Treatment:

By signing this form, you acknowledge that you have been informed about your chosen products and understand the information regarding the risks and benefits of vitamins/amino acid injections, medical weight loss, medical grade skincare, Latisse, and/or IV Therapy. You have had the chance to ask questions about your treatment. Possible complicatins indicated below. 

Intramuscular/IV administration:

• Bruising, swelling, numbness, tingling, dizziness, headaches, scarring.
• Possible fainting from the sight of blood.
Intravenous therapy:
• Extravasation (leakage of IV fluids into surrounding tissue).
• Thrombophlebitis (inflammation of a vein due to a blood clot).
Weight loss medication:
• Headaches, low energy, nausea, constipation, diarrhea.
• Low blood sugar (hypoglycemia) when used with insulin or insulin secretagogues.
• Gastrointestinal issues such as delayed gastric emptying affecting absorption of other oral medications.

Latisse Side Effects:

• Itching and redness of the eyes.
• Dry eyes.
• Eye irritation.
• Darkening of the eyelid skin, which may be reversible.
• Increased brown pigmentation of the colored part of the eye (iris), which is likely to be permanent.
• Hair growth in areas where the Latisse solution frequently touches.

Medical Grade Skincare Common Side Effects:

• Redness, irritation, and peeling of the skin.
• Dryness and flaking.
• Increased sensitivity to sunlight.
• Temporary darkening or lightening of the skin.
• Retinoids:
• Initial worsening of acne.
• Sensitivity to sunlight requiring diligent use of sunscreen.

You understand there may be sensitivity and reactions to injectable solutions and confirm no allergy to niacin. There may be numbness in the injected muscle for a period of time.

Semaglutide/Tirzepatide

• Should not be combined with other GLP-1 receptor agonists.
• The safety and efficacy of coadministration with other products for weight loss are not established.
• Has not been studied in patients with a history of pancreatitis.
Drug Interactions:
• Use with insulin secretagogues increases the risk of hypoglycemia; 
• Semaglutide affects gastric emptying and can impact the absorption of other concomitantly administered oral medications. Monitor effects of oral medications closely.

 Acknowledgement and Release:

• I understand the potential risks and side effects associated with all of our treatment(s).
• I confirm that I do not have any conditions that would contraindicate the chosen treatment.
• I understand that results may vary and are not guaranteed.

You hereby release Solushots/Vydration and all its employees from all liabilities regarding my treatment of my choice. All of our products are non-refundable, but we will be more than happy to exchange or transfer to a friend or family member.